BB&T Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $3.81M | Sell |
14,055
-242
| -2% | -$65.5K | 0.03% | 433 |
|
|
2019
Q2 | $4.47M | Buy |
14,297
+1,914
| +15% | +$599K | 0.04% | 409 |
|
|
2019
Q1 | $5.08M | Sell |
12,383
-377
| -3% | -$155K | 0.05% | 377 |
|
|
2018
Q4 | $4.77M | Buy |
12,760
+227
| +2% | +$84.8K | 0.05% | 368 |
|
|
2018
Q3 | $5.06M | Buy |
12,533
+1,093
| +10% | +$442K | 0.05% | 390 |
|
|
2018
Q2 | $3.95M | Buy |
11,440
+4,038
| +55% | +$1.39M | 0.04% | 430 |
|
|
2018
Q1 | $2.55M | Buy |
7,402
+4,226
| +133% | +$1.45M | 0.03% | 521 |
|
|
2017
Q4 | $1.19M | Buy |
3,176
+145
| +5% | +$54.5K | 0.02% | 683 |
|
|
2017
Q3 | $1.36M | Buy |
3,031
+535
| +21% | +$239K | 0.02% | 645 |
|
|
2017
Q2 | $1.23M | Buy |
2,496
+864
| +53% | +$424K | 0.02% | 655 |
|
|
2017
Q1 | $632K | Buy |
+1,632
| New | +$632K | 0.01% | 806 |
|